FASN and cholangiocarcinoma: Tomacha J et al. [23] proposed that FASN overexpression was closely related to the proliferation, migration and invasion of CCA cells, as well as the poor prognosis and high recurrence risk of patients, and can be used as a biomarker to predict the invasiveness and prognosis of CCA.